No evidence of correlation between mutation at codon 531 of src and the risk of colon cancer in Chinese

Cancer Letters

Volumn 150, Issue 2, 2000, Pages 201-204

  Wang, Nancy M ^a   Yeh, Kun Tu ^b   Tsai, Chan Hai ^a   Chen, Shu Jung ^a   Chang, Jan Gowth ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Chinese; Colon cancer; Polymerase chain reaction; Proto oncogene protein pp60(c src); src

Indexed keywords

DNA;

ARTICLE; CANCER RISK; CHINESE; CODON; COLON CANCER; GENE MUTATION; GENETIC LINKAGE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

CHINA; CODON; COLONIC NEOPLASMS; GENES, SRC; HUMANS; MUTATION; POLYMERASE CHAIN REACTION;

EID: 0033999589     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00398-5     Document Type: Article

References (18)

1. Park J., Cartwrigh C.A. Src activity increases and Yes activity decreases during mitosis of human colon carcinoma cells. Mol. Cell. Biol. 15:1995;2374-2382.
2. Bolen J.B. Non-receptor tyrosine kinase. Oncogene. 8:1993;2025-2031.
3. Rudd C.E., Janssen O., Prasad K.V., Raab M., da Silva A., Telfer J.C., Yamamoto M. Src-related protein tyrosin kinases and their surface receptors. Biochim. Biophys. Acta. 1155:1993;239-266.
4. Kmieck T.E., Shalloway D. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell. 49:1987;75-82.
5. Piwnica-Worms H., Saunders K.B., Roberts T.M., Smith A.E., Cheng S.H. Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell. 49:1987;75-82.
6. Williams J.C., Weijland A., Gonfloni S., Thompson A., Courtneidge S.A., Superti-Furga G., Wierenga R.K. The 2.35 Å crystal structure of the inactivated form of chicken src: a dynamic molecule with multiple regulatory interactions, J. Mol. Biol. 274:1997;757-775.
7. Cooper J.A., Gould K.L., Cartwright C.A., Hunter T. Tyr 527 is phosphorylatd in pp60c-src: implication for regulation. Science. 231:1986;1431-1434.
8. Jove R., Hanafusa H. Cell transformation by the viral src oncogene. Rev. Cell Biol. 3:1987;31-56.
9. Cooper J.A., King C.S. Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src. Mol. Cell Biol. 6:1986;4467-4477.
10. Courmeidge S.A. Activation of pp60c-src kinase by middle T antigen binding or dephosphorylation. EMBO J. 4:1985;1471-1477.
11. Tanaka A., Salem M., Eckroade R.J., Fujita D.J. Characterization of avian retroviruses carrying activated transforming human c-src genes and steps involved in expression of activated src-PKases in vitro. Oncogene Res. 5:1990;305-322.
12. Zheng X., Wang Y., Pallen C.J. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase. Nature. 359:1992;336-339.
13. Ottenhoff-Kalff A.E., Rijksen G., van-Beurden E.A., Hennipman A., Michels A.A., Staal G.E. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res. 52:1992;4773-4778.
14. Talamonti M.S., Roh M.S., Curley S.A., Gallicck G.E. Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J. Clin. Invest. 91:1993;53-60.
15. Masaki T., Okada M., Tokuda M., Shiratori Y., Hatase O., Shirai M., Nishioka M., Omata M. Reduced C-terminal Src kinase (Csk) activities in hepatocelular carcinoma. Hepatology. 29:1999;379-384.
16. Irby R.B., Mao W., Coppola D., Kang J., Loubeau J.M., Trudeau W., Karl R., Fujita D.J., Jove R., Yeatman T.J. Activating SRC mutation in a subset of advanced human colon cancers. Nat. Genet. 21:1999;187-190.
17. Su T.H., Wang J.C., Tseng H.H., Chang C.P., Chang T.A., Wei H.J., Chang J.G. Analysis of FHIT transcripts is cervical and endometrial cancers. Int. J. Cancer. 76:1998;216-222.
18. General health statistics, in: Health and viral Statistics, Republic of China. 1998;86-108 ROC Press, Taipei.